The promise of a longer, healthier life has dominated cultural and medical discourse for centuries. From the early tales of Nicolas Flamel’s Philosopher’s Stone guaranteeing immortality to the latest superfood that promised to reverse aging, we are enthralled by the idea of a longer, more vibrant life. Encouragingly, the longevity industry has proven that a longer, healthier life isn’t just a magazine headline, it’s an achievable reality. Humans will not only live longer, but have more active, healthy and engaged years on this Earth. Research units around the world are making discoveries every day. Medical advances, fueled by intensive research and experimentation, are changing the way scientists, doctors, and even cultural commentators think about how long and how well we can live. We are, indeed, now in the age of longevity.
What is driving these incredible breakthroughs? Pure creativity and innovation. The advent of artificial intelligence, genetic engineering, and renewed interest in public health from the COVID-19 pandemic are catalyzing discoveries at an unprecedented rate. To maximize the impact of these researchers, the future of innovation will have to be collaborative and cooperative. It will take a village to make longevity understandable and accessible to health professionals and individuals alike.
Related: The next generation of data-driven healthcare is here
Where is the future
The best way forward, in my opinion, is to seek the support of true visionaries. Take, for example, the Longenesis company, which I highlighted in my previous post for Cointelegraph. Its ‘blockchain toolkit’ applies the most compelling features of distributed ledger (DLT) technology to protect sensitive medical data, ensure secure sharing of data among multiple partners, and provide patients with a pathway to become stakeholders. of medical research by providing their data and participating in clinical studies. testing. Longenesis could accomplish so much relatively quickly because it had the money and support of the highly futuristic and tolerant blockchain community. Supported by funding from its joint venture partners, Longenesis has achieved its mission of creating a revolutionary, blockchain-based approach to unlocking health data.
This is an increasingly common trend: the Iryo network has relied on the support of blockchain professionals to create a token that allows patients to put their data into play and receive payment from research institutes in exchange of data access. Texas-based EHRData serves a similar goal of decentralized data storage and management by creating a blockchain-based electronic health record that patients can monitor, share, and submit to researchers for milestone rewards. These apps were all made possible by blockchain visionaries ready to fund the future of health and longevity.
Early stage funding can fuel startups, but it can also support even more fundamental innovations by researchers. Truly cutting edge innovation at the laboratory / research stage often requires significant funding for equipment, materials, running administration costs, etc. rush, just to boot. This is a challenge for researchers at smaller institutions, as funding often goes to projects that have access to these resources and, therefore, have already advanced in their discoveries. In these cases, Foundation Grants can help support the high upfront costs associated with finding something to change the world.
The longevity industry is rich with organizations looking to find and fund the next big idea, but very few organizations are willing to go beyond traditional funding models to make it happen. It is difficult to conceive that an industry with innovation at its very heart is lagging behind in terms of new sources of funding, but it is a possible reality facing revolutionary researchers and institutions.
The time of futurists and visionaries
Fortunately, the innovation underway in the digital currency industry spills over into the areas of biotechnology and longevity. The community of visionaries who have transformed the way money and investing work are here to change the way humanity lives life itself.
In 2018, Vitalik Buterin, the co-founder of Ethereum, donated $ 2.4 million in Ether (ETH) to the SENS Research Foundation, a California-based group that works on research, development and promoting comprehensive solutions for diseases associated with aging. Buterin also donated $ 25 million in Shiba Inu Tokens (SHIB) to the Future of Life Institute to fund a doctorate. scholarships focused on ethical applications of artificial intelligence; and millions to the Methuselah Foundation, a tissue engineering research organization to reverse aging processes.
The new Longevity Science Foundation will accept crypto donations to help its goal of extending human lifespan to over 120 years. The Foundation welcomes crypto visionaries, and all donors (both included and encouraged crypto donors), will receive voting rights in the funding selection process.
VitaDAO aims to extend human lifespan in an open and democratic way by researching, funding and marketing longevity therapies. Its decentralized structure is similar to that of many decentralized applications (DApps) and other decentralized autonomous organizations (DAO), creating an exciting new governance structure. Its Genesis auction has raised more than $ 5 million in funding through the purchase of VITA governance tokens, attracting approximately 400 new members committed to the DAO’s mission.
Related: Crypto leaders are obsessed with extending life. here’s why
The crypto visionaries who made these achievements possible are forward-looking collaborators who want a prominent place in cutting-edge longevity science. They are creating a village that will make longevity care possible and accessible to all, but there is still a lot of work to be done. There is a significant overlap between the challenges of adopting longevity care and resistance to blockchain technology and digital currency. By extending our lifespan, we are creating a future that requires the adoption of blockchain and digital currency to be successful.
Digital currencies and blockchain technology have changed the way the whole world processes and uses critical services. These are the fundamental technologies for a more just and efficient society. New applications for DLT are developed every day, and new investors, adopters and appreciators are drawn to the industry due to its ever-changing nature. If we can apply that same entrepreneurial spirit and positive attitude to the longevity industry, our lives will not only be longer, but more enriched, meaningful and digitally activated.
The longevity industry strives to ensure that more people live long enough to enjoy a decentralized and transparent world. To do this, the industry desperately needs the brainpower and experience of the innovators who have turned a single White Paper into a global and unstoppable movement for transparency and equality. This feat was successful once, let’s make it happen again.
The views, thoughts and opinions expressed here are solely those of the author and do not necessarily reflect or represent the views and opinions of Cointelegraph.
Garri Zmudze is a managing partner of LongeVC, a venture capital firm based in Switzerland and Cyprus that accelerates innovative startups in the fields of biotechnology and longevity. He is a seasoned business expert and angel investor with several successful exits in biotechnology and technology companies. He is a long-time supporter and investor in biotech companies including Insilico Medicine, Deep Longevity and Basepaws.
Author’s Note: Longenesis is a holding company of our longevity-focused venture capital firm, LongeVC.